Reversible inactivation of an intracellular uricase from bacillus fastidiosus via dissociation of homotetramer into homodimers in solutions of low ionic strength

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 9, 2009, Pages 2141-2144

  Zhao, Yunsheng ^a,b   Yang, Xiaolan ^a   Li, Xiaoyan ^a   Bu, Youquan ^a   Deng, Ping ^a   Zhang, Chun ^a   Feng, Juan ^a   Xie, Yanling ^a   Zhu, Sha ^a   Yuan, Huidong ^a   Yu, Ming'An ^a   Liao, Fei ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b FIRST HOSPITAL OF QINHUANGDAO   (China)

Author keywords

Dialysis; Dissociation of homotetramer; Inactivation; Ionic strength; Uricase

Indexed keywords

ACRYLAMIDES; GEL ELECTROPHORESIS; GEL-FILTRATION; HIGH IONIC STRENGTH; HOMODIMERS; HOMOTETRAMERS; INACTIVATION; LOW IONIC STRENGTH; PROTEIN ENGINEERING; REVERSIBLE INACTIVATION; SEPHADEX; URICASE;

AMIDES; BACTERIOLOGY; BIOCHEMICAL ENGINEERING; DIALYSIS; DISSOCIATION; ELECTROPHORESIS; GELATION; GELS; GENETIC ENGINEERING; ION EXCHANGE; IONIZATION OF LIQUIDS; SODIUM; SODIUM SULFATE; WATER FILTRATION;

IONIC STRENGTH;

URATE OXIDASE;

ARTICLE; BACILLUS; CHEMISTRY; DIMERIZATION; DRUG ANTAGONISM; ENZYMOLOGY; GEL CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; OSMOLARITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SOLUTION AND SOLUBILITY;

BACILLUS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; OSMOLAR CONCENTRATION; SOLUTIONS; URATE OXIDASE;

BACILLUS FASTIDIOSUS;

EID: 70349687377     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90347     Document Type: Article

References (23)

1. 1) Ramazzina I, Folli C, Secchi A, Berni R, and Percudani R, Nat. Chem. Biol., 2, 144-148 (2006).
2. 2) Becker MA and Jolly M, Rheum. Dis. Clin. North Am., 32, 275-280 (2006).
3. 3) Liao F, Zhao YS, Zhao LN, Tao J, Zhu XY, and Liu L, J. Zhejiang Univ. Sci. B, 7, 497-502 (2006).
4. 4) Zhao YS, Yang XY, Lu W, Liao H, and Liao F, Microchim. Acta, 164,1-6 (2009).
5. 5) Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, and Schreiber MJ, Am. J. Med., 116, 546-554 (2004).
6. 6) Bomalaski JS and Clark MA, Curr. Rheumatol. Rep., 6, 240-247 (2004).
7. 7) Jeha S, Kantarjian H, Irwin D, Shen V, Shenoy S, Blaney S, Camitta B, and Pui CH, Leukemia, 19, 34-38 (2005).
8. 8) Sundy JS and Herbfield MS, Curr. Rheumatol. Rep., 9, 258-264 (2007).
9. 9) Cammalleri L and Malaguarnera M, Int. J. Med. Sci., 4, 83-93 (2007).
10. 10) Biggs K and Scheinfeld N, Curr. Opin. Invest. Drugs, 9, 422-428 (2008).
11. 11) Bertrand Y, Mechinaud F, Brethon B, Mialou V, Auvrignon A, Nelken B, Notz-Carrere A, Plantaz D, Patte C, Urbieta M, Baruchel A, and Leverger G, J. Pediatr. Hematol. Oncol., 30, 267-271 (2008).
12. 12) Zhao YS, Zhao LN, Yang GQ, Tao J, Bu YQ, and Liao F, Biotechnol. Appl. Biochem., 45, 75-80 (2006).
13. 13) Hande KR, Perini F, Putterman GJ, and Elm R, Clin. Chem., 25, 1492-1494 (1979).
14. 14) Harris JM and Chess RB, Nat. Rev. Drug Discov., 2, 214-221 (2003).
15. 15) Veronese FM and Pasut G, Drug Dis. Today, 10, 1451-1458 (2005).
16. 16) Liu BZ, Zhao YS, Zhao LN, Xie YL, Zhu S, Li ZR, Liu Y, Lu W, Yang XL, Xie GM, Zhong HS, Yu MA, Liao H, and Liao F, Anal. Chim. Acta, 631, 22-28 (2009).
17. 17) Bradford MM, Anal. Biochem., 72, 248-254 (1976).
18. 18) Liao F, Zhao LN, Zhao YS, Tao J, and Zuo YP, Anal. Sci., 23, 439-444 (2007).
19. 19) Pohl M, Grotzinger J, Wollmer A, and Kula M-R, Eur. J. Biochem., 224, 651-661 (1994).
20. 20) Butcher S, Hainaut P, and Milner J, Biochem. J., 298, 513-516 (1994).
21. 21) Liu ZX, Lu DN, Li JM, Chen W, and Liu Z, Phys. Chem. Chem. Phys., 11, 333-340 (2009).
22. 22) Chu R, Usdan N, and Yeldandi AV, Ann. NY Acad. Sci., 804, 777-780 (1996).
23. 23) ''Practical Techniques for Protein Electrophoresis,'' ed. Guo YJ, Science Press, Beijing, pp. 70-141 (1990).